-
10:27:44 PM
Sign in with email
Forgot your password?
Register with email
Account Verification

GH Stock News

05/23/22 8:05 AM
Nasdaq : GH
conferences
Guardant Health to Present New Data from its Broad Portfolio of Blood Tests at 2022 American Society of Clinical Oncology (ASCO) Annual Meeting
Guardant Health, Inc., a leading precision oncology company, announced today it will present new data at the 2022 American Society of Clinical Oncology Annual Meeting from June 3-7 in Chicago. Among the 19 abstracts are oral presentations highlighting the use of real-world data to identify resistance to early treatment in advanced breast cancer and the use...
RHEA-AI
neutral
05/21/22 3:01 AM
Nasdaq : GH
Guardant Health Presents New Data Showing Blood Test Accuracy in Detecting Colorectal Cancer in First-of-its Kind Prospective Study at Digestive Disease Week 2022
Guardant Health, Inc., a leading precision oncology company, today announced data showing its blood-based multimodal test achieved clinically significant thresholds of sensitivity and specificity in detecting colorectal cancer. Offering eligible individuals a blood-based test could help overcome many barriers associated with currently available...
RHEA-AI
neutral
05/05/22 8:30 AM
NYSE, Nasdaq : CPNG, GH, TXG
management
Fanatics Announces Appointment of Lydia Jett and Jonathan Mildenhall to Board of Directors
Fanatics, a leading global digital sports platform, today announced the appointment of preeminent fintech, e-commerce and marketing executives Lydia Jett and Jonathan Mildenhall to its board of directors. Lydia, the first female to hold the title of Managing Partner within SoftBank’ s Vision Fund, has nearly twenty years of experience investing in and...
RHEA-AI
positive
05/02/22 8:05 AM
Nasdaq : GH
Guardant Health Announces Shield™ Blood Test Available in US to Detect Early Signs of Colorectal Cancer in Average-Risk Adults
Guardant Health, Inc., a leading precision oncology company, today announced the availability of Shield™, the company’ s first blood-based test for the detection of early-stage colorectal cancer. Colorectal cancer is the second-leading cause of cancer-related deaths in the U.S. 1 Today, one in three adults have not completed the recommended CRC screening even...
RHEA-AI
negative